Köklü, S. Et Al. 2017. Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program. Annals of Hepatology , vol.16, no.1 , 71-76.

Köklü, S., Köksal, I., AKARCA, U. S., Balkan, A., Güner, R., DEMIREZEN, A., ... SAHIN, M.(2017). Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program. Annals of Hepatology , vol.16, no.1, 71-76.

Köklü, İFTAHAR Et Al. "Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program," Annals of Hepatology , vol.16, no.1, 71-76, 2017

Köklü, İFTAHAR Et Al. "Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program." Annals of Hepatology , vol.16, no.1, pp.71-76, 2017

Köklü, S. Et Al. (2017) . "Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program." Annals of Hepatology , vol.16, no.1, pp.71-76.

@article{article, author={İFTAHAR KÖKSAL Et Al. }, title={Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program}, journal={Annals of Hepatology}, year=2017, pages={71-76} }